Surgery may be the best option for prostate cancer patientsNovember 14th, 2007 - 1:53 am ICT by admin
“Therefore, treatment choice is strongly influenced by patient and physician personal preferences and experiences,” the authors write.
Arnaud Merglen, M.D., of Geneva University, Switzerland, and colleagues used data from the Geneva Cancer Registry to assess all 844 patients diagnosed with localized (not yet spread) prostate cancer in Geneva between 1989 and 1998. Of those men, 158 received prostatectomy, or surgery to remove all or part of the prostate; 205 had radiation treatment (radiotherapy); 378 chose watchful waiting, which entails active follow-up and treatment if the disease progresses; 72 underwent hormone therapy; and 31 had another type of therapy.
The average follow-up was 6.7 years (range zero to 15.8 years), and 47 patients (5.6 percent) left Geneva and the study before the study concluded.
“At 10 years, patients treated with radiotherapy or watchful waiting had a significantly increased risk of death from prostate cancer compared with patients who underwent prostatectomy,” the authors write.
Ten-year survival rates from prostate cancer were 83 percent for prostatectomy, 75 percent for radiotherapy, 72 percent for watchful waiting, 41 percent for hormone therapy and 71 percent for other treatment.
“The increased mortality associated with radiotherapy and watchful waiting was primarily observed in patients younger than 70 years and in patients with poorly differentiated tumors,” or tumors that have certain cellular characteristics and are more likely to spread aggressively,” they said.
“Until clinical trials provide conclusive evidence, physicians and patients should be informed of these results and their limitations,” they concluded.
The study appears in the Oct. 8 issue of Archives of Internal Medicine, one of the JAMA/Archives journals. (ANI)
- 'Watchful waiting' often best strategy for low-risk prostate cancer - Jun 19, 2010
- Surgery effective for aggressive prostate cancer patients - Sep 28, 2010
- New tool opens alternate door to prostate cancer diagnosis - Apr 03, 2011
- Aspirin reduces risk of cancer recurrence in prostate cancer patients - May 03, 2011
- Hormone therapy 'doubles survival chances in men with prostate cancer' - Mar 25, 2011
- Prostate cancer treatment 'ups risk of colorectal cancer' - Nov 16, 2010
- Blood vessels could predict how prostate cancer would behave - Nov 04, 2009
- Lymph node removal 'not always needed in early-stage breast cancer' - Feb 09, 2011
- Gastric bypass surgery lead to better long-term results - Feb 22, 2011
- Aspirin use 'cuts risk of death from prostate cancer by more than half' - Oct 26, 2010
- High level of testosterone may speed up prostate cancer - Jul 31, 2012
- New prostate cancer imaging technique can 'see' tumors grow - Dec 03, 2010
- Genomic analysis of prostate cancer unveiled - Jun 26, 2010
- Hormone therapy ups death risk for prostate cancer patients with heart disease - Aug 26, 2009
- PSA test more reliable in men taking prostate-shrinking drug - Dec 18, 2010
Tags: arnaud, cancer registry, conclusive evidence, geneva university, hormone therapy, personal preferences, prostate cancer patients, prostate cancer treatments, prostatectomy, radiation treatment, radiotherapy, randomized trial, range zero, survival rates, treatment choice, tumors, university switzerland, watchful waiting